AKAP5 and gastric adenocarcinoma: Low expression of AKAP5 may be a potential molecular marker for predicting poor prognosis of non-mucin-producing stomach adenocarcinoma (NMSA) via regulating cholesterol homeostasis, estrogen response, glycolysis, notch signaling, and adipogenesis pathways [35].